HR 1269 Introduced Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Honoring Our Fallen Heroes Act of 2025
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to provide public safety officer benefits for exposure-related cancers, and for other purposes.
Summary
This bill, titled the "Honoring Our Fallen Heroes Act of 2025," amends the public safety officer benefits program to include support for cancers related to occupational exposure. The bill establishes a presumption that exposure of a public safety officer to a carcinogen while performing line of duty activities constitutes a compensable line of duty injury if the officer served at least 5 years before diagnosis, was diagnosed within 15 years of last service, and the cancer directly caused death or permanent disability. The bill lists 22 types of exposure-related cancer and requires the Director to review and potentially update the list at least every 3 years based on medical evidence, with a process allowing the public to petition for additions and requiring Congressional notification of substantive actions. The bill also extends the filing deadline for claims related to exposure-related cancers to 3 years from enactment and applies retroactively to deaths and disabilities occurring since January 1, 2020.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
180 cosponsors
- Del. Norton, Eleanor Holmes [D-DC-At Large] (D-DC)
- Rep. Adams, Alma S. [D-NC-12] (D-NC)
- Rep. Aguilar, Pete [D-CA-33] (D-CA)
- Rep. Alford, Mark [R-MO-4] (R-MO)
- Rep. Amo, Gabe [D-RI-1] (D-RI)
- Rep. Ansari, Yassamin [D-AZ-3] (D-AZ)
- Rep. Bacon, Don [R-NE-2] (R-NE)
- Rep. Balint, Becca [D-VT-At Large] (D-VT)
- Rep. Barr, Andy [R-KY-6] (R-KY)
- Rep. Beatty, Joyce [D-OH-3] (D-OH)
- Rep. Bice, Stephanie I. [R-OK-5] (R-OK)
- Rep. Bilirakis, Gus M. [R-FL-12] (R-FL)
- Rep. Boebert, Lauren [R-CO-4] (R-CO)
- Rep. Bonamici, Suzanne [D-OR-1] (D-OR)
- Rep. Bost, Mike [R-IL-12] (R-IL)
- Rep. Boyle, Brendan F. [D-PA-2] (D-PA)
- Rep. Bresnahan, Robert P. [R-PA-8] (R-PA)
- Rep. Brownley, Julia [D-CA-26] (D-CA)
- Rep. Budzinski, Nikki [D-IL-13] (D-IL)
- Rep. Bynum, Janelle [D-OR-5] (D-OR)
- Rep. Carbajal, Salud O. [D-CA-24] (D-CA)
- Rep. Carey, Mike [R-OH-15] (R-OH)
- Rep. Carson, André [D-IN-7] (D-IN)
- Rep. Casar, Greg [D-TX-35] (D-TX)
- Rep. Casten, Sean [D-IL-6] (D-IL)
- Rep. Chu, Judy [D-CA-28] (D-CA)
- Rep. Ciscomani, Juan [R-AZ-6] (R-AZ)
- Rep. Cisneros, Gilbert Ray [D-CA-31] (D-CA)
- Rep. Cleaver, Emanuel [D-MO-5] (D-MO)
- Rep. Conaway, Herbert C. [D-NJ-3] (D-NJ)
- Rep. Connolly, Gerald E. [D-VA-11] (D-VA)
- Rep. Correa, J. Luis [D-CA-46] (D-CA)
- Rep. Costa, Jim [D-CA-21] (D-CA)
- Rep. Craig, Angie [D-MN-2] (D-MN)
- Rep. Crank, Jeff [R-CO-5] (R-CO)
- Rep. Crockett, Jasmine [D-TX-30] (D-TX)
- Rep. Davids, Sharice [D-KS-3] (D-KS)
- Rep. Dean, Madeleine [D-PA-4] (D-PA)
- Rep. DeGette, Diana [D-CO-1] (D-CO)
- Rep. DelBene, Suzan K. [D-WA-1] (D-WA)
- Rep. Deluzio, Christopher R. [D-PA-17] (D-PA)
- Rep. DeSaulnier, Mark [D-CA-10] (D-CA)
- Rep. Dexter, Maxine [D-OR-3] (D-OR)
- Rep. Diaz-Balart, Mario [R-FL-26] (R-FL)
- Rep. Dingell, Debbie [D-MI-6] (D-MI)
- Rep. Doggett, Lloyd [D-TX-37] (D-TX)
- Rep. Elfreth, Sarah [D-MD-3] (D-MD)
- Rep. Evans, Gabe [R-CO-8] (R-CO)
- Rep. Fedorchak, Julie [R-ND-At Large] (R-ND)
- Rep. Fields, Cleo [D-LA-6] (D-LA)
- Rep. Fitzpatrick, Brian K. [R-PA-1] (R-PA)
- Rep. Flood, Mike [R-NE-1] (R-NE)
- Rep. Foster, Bill [D-IL-11] (D-IL)
- Rep. Frankel, Lois [D-FL-22] (D-FL)
- Rep. Friedman, Laura [D-CA-30] (D-CA)
- Rep. Frost, Maxwell [D-FL-10] (D-FL)
- Rep. Garbarino, Andrew R. [R-NY-2] (R-NY)
- Rep. García, Jesús G. "Chuy" [D-IL-4] (D-IL)
- Rep. Garcia, Robert [D-CA-42] (D-CA)
- Rep. Gillen, Laura [D-NY-4] (D-NY)
- Rep. Gimenez, Carlos A. [R-FL-28] (R-FL)
- Rep. Golden, Jared F. [D-ME-2] (D-ME)
- Rep. Goldman, Daniel S. [D-NY-10] (D-NY)
- Rep. Gomez, Jimmy [D-CA-34] (D-CA)
- Rep. Gooden, Lance [R-TX-5] (R-TX)
- Rep. Goodlander, Maggie [D-NH-2] (D-NH)
- Rep. Gottheimer, Josh [D-NJ-5] (D-NJ)
- Rep. Graves, Sam [R-MO-6] (R-MO)
- Rep. Gray, Adam [D-CA-13] (D-CA)
- Rep. Hamadeh, Abraham J. [R-AZ-8] (R-AZ)
- Rep. Harder, Josh [D-CA-9] (D-CA)
- Rep. Hayes, Jahana [D-CT-5] (D-CT)
- Rep. Horsford, Steven [D-NV-4] (D-NV)
- Rep. Houlahan, Chrissy [D-PA-6] (D-PA)
- Rep. Hoyer, Steny H. [D-MD-5] (D-MD)
- Rep. Hoyle, Val T. [D-OR-4] (D-OR)
- Rep. Huffman, Jared [D-CA-2] (D-CA)
- Rep. Ivey, Glenn [D-MD-4] (D-MD)
- Rep. Jackson, Jonathan L. [D-IL-1] (D-IL)
- Rep. Jayapal, Pramila [D-WA-7] (D-WA)
- Rep. Johnson, Henry C. "Hank" [D-GA-4] (D-GA)
- Rep. Johnson, Julie [D-TX-32] (D-TX)
- Rep. Kean, Thomas H. [R-NJ-7] (R-NJ)
- Rep. Keating, William R. [D-MA-9] (D-MA)
- Rep. Kelly, Mike [R-PA-16] (R-PA)
- Rep. Kennedy, Timothy M. [D-NY-26] (D-NY)
- Rep. Kiggans, Jennifer A. [R-VA-2] (R-VA)
- Rep. Kim, Young [R-CA-40] (R-CA)
- Rep. Krishnamoorthi, Raja [D-IL-8] (D-IL)
- Rep. LaLota, Nick [R-NY-1] (R-NY)
- Rep. Landsman, Greg [D-OH-1] (D-OH)
- Rep. Langworthy, Nicholas A. [R-NY-23] (R-NY)
- Rep. Larsen, Rick [D-WA-2] (D-WA)
- Rep. Larson, John B. [D-CT-1] (D-CT)
- Rep. Lawler, Michael [R-NY-17] (R-NY)
- Rep. Lee, Summer L. [D-PA-12] (D-PA)
- Rep. Levin, Mike [D-CA-49] (D-CA)
- Rep. Lieu, Ted [D-CA-36] (D-CA)
- Rep. Lynch, Stephen F. [D-MA-8] (D-MA)
- Rep. Mackenzie, Ryan [R-PA-7] (R-PA)
- Rep. Magaziner, Seth [D-RI-2] (D-RI)
- Rep. Malliotakis, Nicole [R-NY-11] (R-NY)
- Rep. Matsui, Doris O. [D-CA-7] (D-CA)
- Rep. McBath, Lucy [D-GA-6] (D-GA)
- Rep. McBride, Sarah [D-DE-At Large] (D-DE)
- Rep. McClain Delaney, April [D-MD-6] (D-MD)
- Rep. McCollum, Betty [D-MN-4] (D-MN)
- Rep. McDonald Rivet, Kristen [D-MI-8] (D-MI)
- Rep. McGarvey, Morgan [D-KY-3] (D-KY)
- Rep. McGuire, John J. [R-VA-5] (R-VA)
- Rep. Menendez, Robert [D-NJ-8] (D-NJ)
- Rep. Meuser, Daniel [R-PA-9] (R-PA)
- Rep. Mfume, Kweisi [D-MD-7] (D-MD)
- Rep. Miller, Max L. [R-OH-7] (R-OH)
- Rep. Min, Dave [D-CA-47] (D-CA)
- Rep. Morrison, Kelly [D-MN-3] (D-MN)
- Rep. Moulton, Seth [D-MA-6] (D-MA)
- Rep. Mrvan, Frank J. [D-IN-1] (D-IN)
- Rep. Mullin, Kevin [D-CA-15] (D-CA)
- Rep. Neal, Richard E. [D-MA-1] (D-MA)
- Rep. Neguse, Joe [D-CO-2] (D-CO)
- Rep. Norcross, Donald [D-NJ-1] (D-NJ)
- Rep. Nunn, Zachary [R-IA-3] (R-IA)
- Rep. Obernolte, Jay [R-CA-23] (R-CA)
- Rep. Olszewski, Johnny [D-MD-2] (D-MD)
- Rep. Pallone, Frank [D-NJ-6] (D-NJ)
- Rep. Panetta, Jimmy [D-CA-19] (D-CA)
- Rep. Pappas, Chris [D-NH-1] (D-NH)
- Rep. Perez, Marie Gluesenkamp [D-WA-3] (D-WA)
- Rep. Pettersen, Brittany [D-CO-7] (D-CO)
- Rep. Pingree, Chellie [D-ME-1] (D-ME)
- Rep. Pocan, Mark [D-WI-2] (D-WI)
- Rep. Pou, Nellie [D-NJ-9] (D-NJ)
- Rep. Ramirez, Delia C. [D-IL-3] (D-IL)
- Rep. Randall, Emily [D-WA-6] (D-WA)
- Rep. Raskin, Jamie [D-MD-8] (D-MD)
- Rep. Riley, Josh [D-NY-19] (D-NY)
- Rep. Ross, Deborah K. [D-NC-2] (D-NC)
- Rep. Ruiz, Raul [D-CA-25] (D-CA)
- Rep. Rulli, Michael A. [R-OH-6] (R-OH)
- Rep. Ryan, Patrick [D-NY-18] (D-NY)
- Rep. Salazar, Maria Elvira [R-FL-27] (R-FL)
- Rep. Salinas, Andrea [D-OR-6] (D-OR)
- Rep. Schmidt, Derek [R-KS-2] (R-KS)
- Rep. Schneider, Bradley Scott [D-IL-10] (D-IL)
- Rep. Scholten, Hillary J. [D-MI-3] (D-MI)
- Rep. Schrier, Kim [D-WA-8] (D-WA)
- Rep. Sherman, Brad [D-CA-32] (D-CA)
- Rep. Sherrill, Mikie [D-NJ-11] (D-NJ)
- Rep. Shreve, Jefferson [R-IN-6] (R-IN)
- Rep. Simon, Lateefah [D-CA-12] (D-CA)
- Rep. Smith, Christopher H. [R-NJ-4] (R-NJ)
- Rep. Sorensen, Eric [D-IL-17] (D-IL)
- Rep. Stansbury, Melanie A. [D-NM-1] (D-NM)
- Rep. Stauber, Pete [R-MN-8] (R-MN)
- Rep. Strickland, Marilyn [D-WA-10] (D-WA)
- Rep. Subramanyam, Suhas [D-VA-10] (D-VA)
- Rep. Suozzi, Thomas R. [D-NY-3] (D-NY)
- Rep. Swalwell, Eric [D-CA-14] (D-CA)
- Rep. Sykes, Emilia Strong [D-OH-13] (D-OH)
- Rep. Tenney, Claudia [R-NY-24] (R-NY)
- Rep. Thanedar, Shri [D-MI-13] (D-MI)
- Rep. Thompson, Bennie G. [D-MS-2] (D-MS)
- Rep. Thompson, Glenn [R-PA-15] (R-PA)
- Rep. Titus, Dina [D-NV-1] (D-NV)
- Rep. Torres, Norma J. [D-CA-35] (D-CA)
- Rep. Torres, Ritchie [D-NY-15] (D-NY)
- Rep. Trahan, Lori [D-MA-3] (D-MA)
- Rep. Tran, Derek [D-CA-45] (D-CA)
- Rep. Turner, Michael R. [R-OH-10] (R-OH)
- Rep. Underwood, Lauren [D-IL-14] (D-IL)
- Rep. Valadao, David G. [R-CA-22] (R-CA)
- Rep. Van Drew, Jefferson [R-NJ-2] (R-NJ)
- Rep. Vasquez, Gabe [D-NM-2] (D-NM)
- Rep. Veasey, Marc A. [D-TX-33] (D-TX)
- Rep. Vindman, Eugene [D-VA-7] (D-VA)
- Rep. Wagner, Ann [R-MO-2] (R-MO)
- Rep. Walkinshaw, James R. [D-VA-11] (D-VA)
- Rep. Wasserman Schultz, Debbie [D-FL-25] (D-FL)
- Rep. Wittman, Robert J. [R-VA-1] (R-VA)
Money behind the sponsor
Top reported contributors to Mary Gay Scanlon’s campaign committee (2024 cycle) — who funds the bill’s sponsor, not a claim about this bill. Data from FEC.
- BALLARD SPAHR LLP $35,392
- BALLARD SPAHR $32,750
- UNIVERSITY OF PENNSYLVANIA $10,450
- NULL $9,550
- AMERISOURCEBERGEN CORPORATION $6,600
Organizations whose employees gave the most — itemized individual contributions grouped by the donor’s reported employer (FEC Schedule A). Full finance for Mary Gay Scanlon → · Outside spending →
Actions (2)
- Feb 12, 2025 Referred to the House Committee on the Judiciary. · house
- Feb 12, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
February 12, 2025
Ms. Scanlon (for herself, Mr. Gimenez, Mr. Fitzpatrick, and Mr. Amo) introduced the following bill; which was referred to the Committee on the Judiciary
A BILL
To amend the Omnibus Crime Control and Safe Streets Act of 1968 to provide public safety officer benefits for exposure-related cancers, and for other purposes.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Honoring Our Fallen Heroes Act of 2025”.
SEC. 2. HONORING OUR FALLEN HEROES.
(a) Cancer-Related Deaths and Disabilities.—
(1) In general.—Section 1201 of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10281) is amended by adding at the end the following:
“(p) Exposure-Related Cancers.—
“(1) Definitions.—In this subsection:
“(A) Carcinogen.—The term ‘carcinogen’ means an agent that is—
“(i) classified by the International Agency for Research on Cancer under Group 1 or Group 2A; and
“(ii) reasonably linked to an exposure- related cancer.
“(B) Director.—The term ‘Director’ means the Director of the Bureau.
“(C) Exposure-related cancer.—As updated from time to time in accordance with paragraph (3), the term ‘exposure-related cancer’ means—
“(i) bladder cancer;
“(ii) brain cancer;
“(iii) breast cancer;
“(iv) cervical cancer;
“(v) colon cancer;
“(vi) colorectal cancer;
“(vii) esophageal cancer;
“(viii) kidney cancer;
“(ix) leukemia;
“(x) lung cancer;
“(xi) malignant melanoma;
“(xii) mesothelioma;
“(xiii) multiple myeloma;
“(xiv) non-Hodgkins lymphoma;
“(xv) ovarian cancer;
“(xvi) prostate cancer;
“(xvii) skin cancer;
“(xviii) stomach cancer;
“(xix) testicular cancer;
“(xx) thyroid cancer;
“(xxi) any form of cancer that is considered a WTC-related health condition under section 3312(a) of the Public Health Service Act (42 U.S.C. 300mm-22(a)); and
“(xxii) any form of cancer added to this definition pursuant to an update in accordance with paragraph (3).
“(2) Personal injury sustained in the line of duty.—
“(A) In general.—Subject to subparagraph (B), as determined by the Bureau, the exposure of a public safety officer to a carcinogen shall be presumed to constitute a personal injury within the meaning of subsection (a) or (b) sustained in the line of duty by the officer and directly and proximately resulting in death or permanent and total disability, if—
“(i) the exposure occurred while the public safety officer was engaged in line of duty action or activity;
“(ii) the public safety officer began serving as a public safety officer not fewer than 5 years before the date of the diagnosis of the public safety officer with an exposure- related cancer;
“(iii) the public safety officer was diagnosed with the exposure-related cancer not more than 15 years after the public safety officer’s last date of active service as a public safety officer; and
“(iv) the exposure-related cancer directly and proximately results in the death or permanent and total disability of the public safety officer.
“(B) Exception.—The presumption under subparagraph (A) shall not apply if competent medical evidence establishes that the exposure of the public safety officer to the carcinogen was not a substantial contributing factor in the death or disability of the public safety officer.
“(3) Additional exposure-related cancers.—
“(A) In general.—From time to time but not less frequently than once every 3 years, the Director shall—
“(i) review the definition of ‘exposure- related cancer’ under paragraph (1); and
“(ii) if appropriate, update the definition, in accordance with this paragraph—
“(I) by rule; or
“(II) by publication in the Federal Register or on the public website of the Bureau.
“(B) Basis for updates.—
“(i) In general.—The Director shall make an update under subparagraph (A)(ii) in any case in which the Director finds such an update to be appropriate based on competent medical evidence of significant risk to public safety officers of developing the form of exposure- related cancer that is the subject of the update from engagement in their public safety activities.
“(ii) Evidence.—The competent medical evidence described in clause (i) may include recommendations, risk assessments, and scientific studies by—
“(I) the National Institute for Occupational Safety and Health;
“(II) the National Toxicology Program;
“(III) the National Academies of Sciences, Engineering, and Medicine; or
“(IV) the International Agency for Research on Cancer.
“(C) Petitions to add to the list of exposure- related cancers.—
“(i) In general.—Any person may petition the Director to add a form of cancer to the definition of ‘exposure-related cancer’ under paragraph (1).
“(ii) Content of petition.—A petition under clause (i) shall provide information to show that there is sufficient competent medical evidence of significant risk to public safety officers of developing the cancer from engagement in their public safety activities.
“(iii) Timely and substantive decisions.—
“(I) Referral.—Not later than 180 days after receipt of a petition satisfying clause (ii), the Director shall refer the petition to appropriate medical experts for review, analysis (including risk assessment and scientific study), and recommendation.
“(II) Consideration.—The Director shall consider each recommendation under subclause (I) and promptly take appropriate action in connection with the recommendation pursuant to subparagraph (B).
“(iv) Notification to congress.—Not later than 30 days after taking any substantive action in connection with a recommendation under clause (iii)(II), the Director shall notify the Committee on the Judiciary of the Senate and the Committee on the Judiciary of the House of Representatives of the substantive action.”.
(2) Applicability.—The amendment made by paragraph (1) shall apply to any claim under—
(A) section 1201(a) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10281(a)) that is predicated upon the death of a public safety officer on or after January 1, 2020, that is the direct and proximate result of an exposure-related cancer; or
(B) section 1201(b) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10281(b)) that is filed on or after January 1, 2020, and predicated upon a disability that is the direct and proximate result of an exposure-related cancer.
(3) Time for filing claim.—Notwithstanding any other provision of law, an individual who desires to file a claim that is predicated upon the amendment made by paragraph (1) shall not be precluded from filing such a claim within 3 years of the date of enactment of this Act.
(b) Confidentiality of Information.—
(1) In general.—Section 812(a) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10231(a)) is amended—
(A) in the first sentence, by striking “furnished under this title by any person and identifiable to any specific private person” and inserting “furnished under any law to any component of the Office of Justice Programs, or furnished otherwise under this title, by any entity or person, including any information identifiable to any specific private person,”; and
(B) in the second sentence, by striking “person furnishing such information” and inserting “entity or person furnishing such information or to whom such information pertains”.
(2) Effective date; applicability.—The amendments made by paragraph (1) shall—
(A) shall take effect for all purposes as if enacted on December 27, 1979; and
(B) apply to any matter pending, before the Department of Justice or otherwise, as of the date of enactment of this Act.
(c) Technical Amendments.—
(1) In general.—Section 1201(o)(2) of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10281(o)(2)) is amended—
(A) in subparagraph (A), by inserting “or (b)” after “subsection (a)”;
(B) in subparagraph (B), by inserting “or (b)” after “subsection (a)”; and
(C) in subparagraph (C), by inserting “or (b)” after “subsection (a)”.
(2) Applicability.—The amendments made by paragraph (1) shall apply to any matter pending before the Department of Justice as of the date of enactment of this Act.
SEC. 3. TECHNICAL AMENDMENTS.
(a) In General.—Section 3 of the Safeguarding America’s First Responders Act of 2020 (34 U.S.C. 10281 note) is amended by adding at the end the following:
“(d) Definition.—In this section, the term ‘line of duty action’ includes any action—
“(1) in which a public safety officer engaged at the direction of the agency served by the public safety officer; or
“(2) the public safety officer is authorized or obligated to perform.”.
(b) Applicability.—
(1) In general.—The amendment made by subsection (a) shall apply to any claim under section 3 of the Safeguarding America’s First Responders Act of 2020 (34 U.S.C. 10281 note)—
(A) that is predicated upon the death of a public safety officer on or after January 1, 2020; or
(B) that is—
(i) predicated upon the disability of a public safety officer; and
(ii) filed on or after January 1, 2020.
(2) Time for filing claim.—Notwithstanding any other provision of law, an individual who desires to file a claim that is predicated upon the amendment made by subsection (a) shall not be precluded from filing such a claim within 3 years of the date of enactment of this Act. <all>
Comments